| CWPW PHYSICIANS ARE CONDUCTING IMPORTANT MEDICAL RESEARCH |
Some of the finest pediatric subspecialty care physicians in the region are associated with CWPW. Many of these respected doctors have conducted or are undertaking important leadership roles in the advancement of child medicine through research efforts on the state or national levels. Additionally, many CWPW physicians belong to or serve on committees and organizations dedicated to promoting child health and well-being. |
|
Lance Parton, MD is a Neonatologist at CWPW and Professor of Pediatrics, Obstetrics and Gynecology and Anesthesiology at New York Medical College , and Associate Professor of the Regional Neonatal Intensive Care Unit at Maria Fareri Children's Hospital at Westchester Medical Center . Dr. Parton is the Vice-President of New York Chapter 3 of the American Academy of Pediatrics and is past chairperson for the Committee on Fetus and Newborn for this Chapter. He is also active in the American Thoracic Society (Assembly on Pediatrics, Program Committee). His research investigates the genetic foundations of conditions that contribute to prematurity, as well as the complications of prematurity. Dr. Parton's laboratory has investigated the role of single nucleotide polymorphisms (SNPs) in the development of preterm prolonged rupture of membranes (PPROM), intrauterine growth retardation (IUGR), and preeclampsia in collaboration with Obstetrics and Maternal Fetal Medicine.
The complications of preterm infants such as bronchopulmonary dysplasia (BPD) and patent ductus arteriosus (PDA) are also active areas of investigation. Susceptibility to respiratory syncytial virus (RSV) bronchiolitis, as well as variability of responsiveness to albuterol in infants with RSV bronchiolitis has been undertaken in collaboration with Pediatric Pulmonology, Allergy and Sleep Medicine.
Clinical areas of investigation include comparative studies of surfactants, high frequency ventilation, and exhaled nitric oxide in ventilated preterm infants, as well as the effects of music therapy on preterm infants, the latter in collaboration with music therapist, Laurie Park.
|
|
|
Julian Stewart, MD, PhD is a Pediatric Cardiologist at CWPW and Professor of Pediatrics and Physiology at New York Medical College. In addition to earning an MD, he also has a Ph.D. in biophysics. Dr. Stewart currently holds three NIH grants and is interviewing for the Clinical Integrative Cardiovascular study section of the NIH. He regularly presents to and will be a member of the faculty at the American Heart Association, American College of Cardiology, American Physiological Society, and the American Autonomic Society. Dr. Stewart has conducted significant research since 1984. One NIH-funded study, “Circulatory Dysfunction in Chronic Fatigue Function,” is ongoing and seeks to determine the causes of Chronic Fatigue Syndrome (CFS) in adolescents. He has also published hundreds of original articles and abstracts, made countless peer presentations, and written seven books on pediatric medicine.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
|
|
|
Markus Erb, MD is a Pediatric Cardiologist with CWPW, as well as Director of the Cardiac Catheterization Lab and Director of Pediatric Interventional Cardiology at Maria Fareri Children's Hospital at Westchester Medical Center . He is a member of the American Heart Association / Cardiovascular Disease in the Young and is currently President of the Pediatric Cardiology Society of Greater New York. Dr. Erb is also Assistant Professor of Pediatrics at New York Medical College . Dr. Erb's areas of research interest include Investigational Device Use: Amplatzer Occluder Devices for Congenital Heart Defects, having served as a Principal Investigator in RESPECT (Randomized Evaluation of Recurrent Stroke, Comparing PFO Closure to Established Current Standard of Care Treatment). Among his philanthropic pursuits is serving on the Board of Directors of the Make-A-Wish Foundation of the Hudson Valley.
.
.
.
.
.
.
|
|
|
Sergio Golombek, MD is Associate Professor of Pediatrics and Clinical Public Health at New York Medical College. He is an attending Neonatologist at the Regional Neonatal Center of the Maria Fareri Children's Hospital at Westchester Medical Center. He is the past president of the New York Perinatal Society, member of the American Academy of Pediatrics, the Society for Pediatric Research, the American Public Health Association and the Ibero-American Society of Neonatology.
His research has included the use of inhaled nitric oxide in newborn babies (for pulmonary hypertension in term and late-term infants, and for prevention of chronic lung disease in preterm infants). In addition, Dr. Golombek participated as a Site-PI in the NIH-sponsored trial “NO-CLD,” published in the New England Journal of Medicine in 2006 He served as a co-PI with Edmund La Gamma, MD in a National Institute of Neurological Disorders and Stroke (NINDS)-sponsored trial regarding supplementation of thyroid hormone to extremely low birth weight infants with transient hypothyroxinemia of prematurity. A Phase 3 study in the same area is being planned. |
|
|
Allen Dozor, MD is very much involved with medical research and investigation. As Director of the Children's Environmental Health Center of the Hudson Valley at CWPW, Dr. Dozor is a member of the Child Health Protection Committee of the United States Environmental Protection Agency. Dr. Dozor is also Director of both the American Lung Association Asthma Clinical Research Center and the Armond V. Mascia, MD Cystic Fibrosis Center, both based in Valhall , New York. As part of the Pediatric Pulmonology, Allergy and Sleep Medicine group at CWPW, Dr. Dozor and his colleagues have and continue to perform real-world clinical trials on asthma for the American Lung Association. The Maria Fareri Children's Hospital / New York Medical College (NYMC) is also one of 115 clinical care centers (one of five in the New York metropolitan area) accredited by the Cystic Fibrosis Foundation, investigating how to bring new therapies to the approximately 25,000 cystic fibrosis patients nationwide. |
|
|
Praveen Ballabh, MD has been involved in a considerable amount of research, and has a number of ongoing research efforts. He is Primary Investigator in a $1.4 million NIH grant running through 2014 to study white matter injury after brain hemorrhage of premature rabbits and humans. A second NIH grant, in which Dr. Ballabh is Primary Investigator, runs through 2011 and studies elevated chondroitin levels in newborns. Also under way is an American Heart Grant in aid running through 2012. Dr. Ballabh has completed research efforts for Pfizer, the Maria Fareri Children's Hospital Foundation, the NIH, Q Therapeutics, United Cerebral Palsy, as well as independent research.
.
.
.
.
.
|
|
Edmund F. LaGamma, MD
Neonatology
Edmund F. LaGamma, MD is Chief of Newborn Medicine at Maria Fareri Children's Hospital at Westchester Medical Center. Dr. La Gamma directs one of the largest Neonatal-Perinatal Medicine Fellowship Programs in the United States with 13 trainees. Dr. La Gamma has received funding as the Principal Investigator from the National Institutes of Health, the National Science Foundation, the American Heart Association, the March of Dimes Foundation, the Dysautonomia Foundation and from various industry sources. He is widely published and holds two patents: one on gene therapy in the central nervous system; and another in use of cytokines to treat neonatal infections. He has been a Council leader for the Society for Pediatric Research and other national organizations.
.
.
|
|
Michael H. Gewitz MD, Vice President of CWPW and Chief of Cardiology at Maria Fareri Children's Hospital, was recently elected as National Chairperson of the Council on Cardiovascular Disease in the Young (CVDY) of The American Heart Association. This is one of the AHA's 12 scientific concils overseeing research, training, and clinical guideline development in Pediatric Cardiology for the largest US scientific philanthropic organization. Dr. Gewitz was co-author of the recent AHA guideline statement on endocarditis prophylaxis. He has been Associate Editor of the Journal Heart Disease, and is section co-editor for Cardiovascular Review. Dr. Gewitz is a fellow of numerous state and national societies including AOA, the medical school honor society, the NY Academy of Medicine, the Pediatric Academic Societies, the American Heart Association, and the American College of Cardiology among others.
|
|
David F. Kronn, MD
Medical Genetics
David F. Kronn, MD is Chief of Pediatric Medical Genetics at CWPW and Associate Professor of Pediatrics at New York Medical College. He is Director of the Inherited Metabolic Disease Center at Maria Fareri Children's Hospital / Westchester Medical Center, the Newborn Screening Referral Center, the Biochemical Genetics Laboratory, and of the Regional Medical Genetics Cente , all in Valhalla, NY. Dr. Kronn serves on the New York State Task Force for Newborn Screening, the Advisory Committee to Review the development of newborn screening in New York State . He also participates in the New York Mid-Atlantic Consortium Work Group 4 Chair for Newborn Screening Standardization Work and holds a research grant to study metabolic disorders and the breakdown of proteins.
|
|
Mehmet Fevzi Ozkaynak, MD is a member of Hematology / Oncology at CWPW and at New York Medical College where he is Professor of Pediatrics. He is the Director of Pediatric Hematology / Oncology and Pediatric Blood and Marrow Transplant Program at Maria Fareri Children's Hospital at Westchester Medical Center. For the past eight years Dr. Ozkaynak served as the Vice-Chairperson of the Children's Oncology Group (COG) protocol to study best treatments for children with neuroblastoma. He is currently the Chair of a COG protocol aimed for Federal Drug Administration (FDA) Biological License application for immunotherapy in patients with advanced neuroblastoma. He chaired several other pediatric oncology projects dedicated to researching childhood cancer, in addition to the COG which is the largest group in North America that treats children with unified state-of-the-art protocols.
|
|
|
|
|
|
